The Precision Medicine Market size is set to exceed $96 billion dollars by 2024; according to a new research report by Global Market Insights. The new report reveals the rising prevalence of cancer across the globe fueling the need to develop target specific biomarkers based on the individual genetic, environmental and lifestyle factors augmenting the global precision medicine market size.Advancement in cancer biology coupled with increased funding for cancer research will fuel industry
Read More
hc1.com Raises $10M to Expand Precision Health Platform for Value-based Care
hc1.com, an Indianapolis, IN-based precision medicine startup, announced that existing investor Health Cloud Capital has exercised its option to provide additional growth funding, bringing the company’s total Series B capital raise to $10 million. Elevate Ventures also participated in the round. The additional capital will fund continued expansion of precision health initiatives underway at hc1, including solutions that combat the opioid crisis and optimize prescribing of other prescription
Read More
Akouos Raises $50M to Advance Precision Medicine for Hearing Disorders
Akouos, a Boston, MA-based precision genetic medicine company developing gene therapies that restore and preserve hearing has raised $50 million in Series A funding co-led by 5AM Ventures and New Enterprise Associates (NEA) with participation from existing investor Partners Innovation Fund and new investors Sofinnova Ventures, RA Capital Management and Novartis Venture Fund. The company plans to use the funding round to advance its lead program to first-in-human clinical trials and bolster its
Read More
Click Therapeutics Lands $17M to Advance Prescription Digital Therapeutics Platform
Click Therapeutics, Inc. (“Click”), a provider of Digital Therapeutics solutions as prescription medical treatments, has raised $17 million in funding led by Sanofi Ventures, the corporate venture capital arm of Sanofi. Sanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new products and technologies of strategic interest to Sanofi. Among these areas are rare diseases, vaccines, potential cures in other core areas of Sanofi’s
Read More
DreaMed Diabetes Granted FDA Approval for Personalized Diabetes Decision Support Solution
DreaMed Diabetes, an Israeli-based developer of personalized diabetes management solutions, today announced that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software. Advisor Pro is indicated to assist healthcare providers in the management of people with type 1 diabetes who use insulin pumps and continuous glucose monitoring (CGM).The announcement marks the second
Read More
Syapse Precision Medicine Council Launches to Advance Precision Oncology Adoption
Syapse, a San Francisco, CA-based precision medicine company, announced today the formation of the Syapse Precision Medicine Council, a group of oncology, operations, and research leaders from health systems dedicated to advancing precision oncology adoption through sharing best practices.Inaugural members include Henry Ford Health System, Catholic Health Initiatives and Dignity Health (the Precision Medicine Alliance), Providence St. Joseph Health, Aurora Health Care, and the University of
Read More
5 Ways SmartTrials is Advancing Precision Medicine Through Genomics
Foundation Medicine’s Dr. Gaurav Singal shares how his company’s platform is changing the game in clinical trials and bolstering precision medicine through genomics.The evolution may be slow going, but it looks like precision medicine is destined to disrupt many aspects of healthcare, and it’s already demonstrating that transformative power in clinical trials—where patient recruitment and retention have long plagued the process, according to Foundation Medicine’s Dr. Gaurav Singal.“Current
Read More
Fitango Health Unveils Oncology Precision Medicine App for Providers to Achieve Value-Based Goals
Fitango Health, a provider of integrated care management and patient engagement software, is announcing a transformative new solution, called Fitango Oncology. Fitango Health's innovative application allows healthcare providers to achieve value-based goals through end-to-end engagement spanning the continuum of care.This end-to-end solution is the first of its kind for both oncology and chronic care to integrate decision-support, treatment communication, along with enabling and engaging both
Read More
2bPrecise and PierianDx Team Up to Offer Precision Medicine Solution for Providers
2bPrecise, an EHR-agnostic, cloud-based precision medicine platform, today announced it is collaborating with PierianDx, Inc., the leading clinical genomics knowledge base company, to offer a comprehensive precision medicine solution. The combined solution brings together genomic and clinical data to help providers make more informed care decisions for their patients. This unique technology enables clinicians to concentrate on the most important information to determine what is best for each
Read More
Aspire, LG Health Launches $300M Precision Medicine Fund for Personalized Devices
Aspire Universal, a private equity firm and venture company today announced the establishment of the $300M Aspire Ventures Precision Medicine Fund (AVP) to accelerate innovation for personalized devices and medical practices. Precision medicine is one of the most important transformations ever to come to medicine, and by shifting away from one-size-fits-all solutions, precision medicine offers personalized solutions that deliver better experiences and better outcomes at a lower cost. The AVP
Read More